Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

MAP Pharmaceuticals (MAPP) says the FDA has issued a Complete Response letter to its New Drug...

  • Monday, March 26, 2012, 8:40 PM ET
    MAP Pharmaceuticals (MAPP) says the FDA has issued a Complete Response letter to its New Drug Application for Levadex. The FDA didn't cite clinical safety or efficacy issues, nor request any additional clinical studies be conducted prior to approval. It did however, request the company address issues relating to chemistry, manufacturing and controls and observations from a recent facility inspection of a third party manufacturer. Shares +7% AH.
Track new comments on this story

This news story has 3 comments:

  •  
    Where are you seeing +7% AH? It was +7% during regular hours, then trading was stopped.
    26 Mar 2012, 10:27 PM Reply Like
  •  
    dsr70, you are right, it was +6.92 during regular trading hours before it was halted ~2pm, so I don't know where this +7% is coming...hopeful thinking :)
    26 Mar 2012, 11:29 PM Reply Like
  •  
    Hopeful indeed, and I was hoping too. I'm going to be burned tmrw :(
    26 Mar 2012, 11:36 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »